OK
Plastics & Elastomers
Industry News

DuPont Opens Biopharma Tubing Manufacturing Facility in South Carolina

Published on 2022-08-03. Edited By : SpecialChem

TAGS:  Medical    Part Design & Manufacturing   

DuPont Biopharma tubing manufacturing siteDuPont opened its new DuPont™ Liveo™ Healthcare Solutions manufacturing facility at the Cooper River Site in South Carolina.

The new facility will expand capacity for biopharmaceutical tubing extrusion to meet increased demand from Liveo™ customers.

High-performance Healthcare Solutions


The site, located near Moncks Corner, South Carolina operates using the same quality standards as the DuPont Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan – DuPont’s long-standing healthcare manufacturing site. Operators at the new South Carolina facility were certified at HIMS.

The Cooper River site will bring additional production capacity online over the next two years to serve strategic customers and expand our Liveo™ Healthcare Solutions customer base,” said DuPont Healthcare & Specialty Lubricants global business director Eugenio Toccalino.

We’re committed to investing in our healthcare business, and this biopharma processing manufacturing investment at Cooper River is a key milestone in our growth strategy that will help us offer a highly reliable and sustainable product supply.

DuPont worked with local companies – including more than 40 subcontractors on the site expansion project.

Being selected as the second dedicated healthcare site is indeed an honor and a reflection of our team’s track record of dedication, ownership, and commitment to our Core Values and excellence in meeting customers’ needs. Thanks to collaboration between the DuPont team and our contractor partners, the Cooper River site was completed within 17 months – on time, on budget, and without a single recordable safety incident,” said Bill Alexander, DuPont Cooper River site unit leader. “The opening of the site already has enabled the creation of 25 jobs for startup, with another 25 expected by mid-2024 as we ramp up operations.

DuPont is demonstrating its commitment to serving the healthcare market and its customers with this expansion of its manufacturing footprint, offering high-quality, high-performance solutions, and supporting regulatory actions that address healthcare customers’ specific needs and challenges.

In addition to the Cooper River expansion, in the second half of 2022, the company expects to add biopharma silicone tubing capacity in China to serve the fast-growing customers in that region.

Source: DuPont

medical-channel-newpart-design-channel


Back to Top